AMH-PH(AMH-PH)
AMH-PH
Q3 2026 EPS Estimate
$0.18
Jul 30, 2026
Revenue Estimate
$466M
FY2026E EPS$0.88
FY2027E EPS$0.79
Analyst Sentiment
Wall St. Consensus
Buy19 analysts·Moderate coverage
63
Score
10 Buy (53%)9 Hold (47%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
1053%
Hold
947%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
No analyst price targets available for AMH-PH
Analyst coverage may not be available for this symbol
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+3.47%
EPS-10.64%
FY2028
Rev+5.12%
EPS-10.98%
FY2029
Rev+1.05%
EPS+22.41%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $1.90B | $1.96B | $2.06B | $2.08B |
| Low | $1.88B | $1.92B | $2.03B | $2.05B |
| High | $1.91B | $2.02B | $2.10B | $2.13B |
| EBITDA Avg | $1.43B | $1.48B | $1.56B | $1.57B |
| Low | $1.42B | $1.45B | $1.53B | $1.55B |
| High | $1.44B | $1.53B | $1.59B | $1.61B |
| EBIT Avg | $974M | $1.01B | $1.06B | $1.07B |
| Low | $964M | $986M | $1.04B | $1.05B |
| High | $981M | $1.04B | $1.08B | $1.09B |
| Net Income Avg | $328M | $293M | $261M | $319M |
| Low | $321M | $287M | $255M | $313M |
| High | $336M | $300M | $267M | $327M |
| EPS Avg | $0.88 | $0.79 | $0.70 | $0.86 |
| Low | $0.87 | $0.77 | $0.69 | $0.84 |
| High | $0.91 | $0.81 | $0.72 | $0.88 |
| Analysts (Rev / EPS) | 13 / 1 | 13 / 1 | 8 / 1 | 12 / 1 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $488M | $470M | $488M | $483M | $506M | $487M | $499M | $502M |
| Low | $473M | $456M | $474M | $469M | $491M | $473M | $484M | $487M |
| High | $493M | $475M | $494M | $489M | $512M | $493M | $505M | $508M |
| EBITDA Avg | $368M | $355M | $369M | $365M | $382M | $368M | $377M | $379M |
| Low | $357M | $344M | $358M | $354M | $371M | $357M | $365M | $368M |
| High | $373M | $359M | $373M | $369M | $387M | $372M | $381M | $384M |
| EBIT Avg | $250M | $241M | $251M | $248M | $260M | $250M | $256M | $258M |
| Low | $243M | $234M | $243M | $241M | $252M | $243M | $248M | $250M |
| High | $253M | $244M | $254M | $251M | $263M | $253M | $259M | $261M |
| Net Income Avg | $66M | $70M | $67M | $71M | $74M | $74M | $73M | $65M |
| Low | $63M | $68M | $65M | $68M | $71M | $71M | $70M | $62M |
| High | $67M | $71M | $68M | $72M | $75M | $75M | $74M | $66M |
| EPS Avg | $0.18 | $0.19 | $0.18 | $0.19 | $0.20 | $0.20 | $0.20 | $0.18 |
| Low | $0.17 | $0.19 | $0.18 | $0.19 | $0.20 | $0.20 | $0.19 | $0.17 |
| High | $0.18 | $0.20 | $0.19 | $0.20 | $0.21 | $0.21 | $0.20 | $0.18 |
| Analysts (Rev / EPS) | 11 / 1 | 5 / 1 | 5 / 1 | 6 / 1 | 9 / 1 | 5 / 1 | 4 / 1 | 6 / 1 |
Earnings Surprises
Recent Analyst Actions
No recent analyst actions